These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37506522)

  • 1. Inhibition of the MLCK/MLC2 pathway protects against intestinal heat stroke-induced injury in rats.
    Du L; Zhu L; Lu X; Yu Y; Liu P; Pan J
    J Therm Biol; 2023 Aug; 116():103655. PubMed ID: 37506522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myosin light chain kinase mediates intestinal barrier dysfunction via occludin endocytosis during anoxia/reoxygenation injury.
    Jin Y; Blikslager AT
    Am J Physiol Cell Physiol; 2016 Dec; 311(6):C996-C1004. PubMed ID: 27760753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chang'an II Decoction ( II )-Containing Serum Ameliorates Tumor Necrosis Factor-α-Induced Intestinal Epithelial Barrier Dysfunction via MLCK-MLC Signaling Pathway in Rats.
    Chen T; Yin XL; Kang N; Wang XG; Li BS; Ji HJ; Zhang YQ; Bian LQ; Zhang BH; Wang FY; Tang XD
    Chin J Integr Med; 2020 Oct; 26(10):745-753. PubMed ID: 31768870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-Arginine alleviates heat stress-induced intestinal epithelial barrier damage by promoting expression of tight junction proteins via the AMPK pathway.
    Xia Z; Huang L; Yin P; Liu F; Liu Y; Zhang Z; Lin J; Zou W; Li C
    Mol Biol Rep; 2019 Dec; 46(6):6435-6451. PubMed ID: 31576512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MMP-9-induced increase in intestinal epithelial tight permeability is mediated by p38 kinase signaling pathway activation of MLCK gene.
    Al-Sadi R; Youssef M; Rawat M; Guo S; Dokladny K; Haque M; Watterson MD; Ma TY
    Am J Physiol Gastrointest Liver Physiol; 2019 Feb; 316(2):G278-G290. PubMed ID: 30543452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexmedetomidine protects against burn-induced intestinal barrier injury via the MLCK/p-MLC signalling pathway.
    Qin C; Jiang Y; Chen X; Bian Y; Wang Y; Xie K; Yu Y
    Burns; 2021 Nov; 47(7):1576-1585. PubMed ID: 33933302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Jiawei Baitouweng Decoction affects intestinal mucosal tight junction proteins in rats with ulcerative colitis through p38 MAPK-MLCK signaling pathway].
    Zhang PP; Yang X; Liang GQ; Zhu HP; Zhu H; Wang M; Sun HW
    Zhongguo Zhong Yao Za Zhi; 2021 Nov; 46(21):5719-5726. PubMed ID: 34951226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wogonoside alleviates colitis by improving intestinal epithelial barrier function via the MLCK/pMLC2 pathway.
    Huang S; Fu Y; Xu B; Liu C; Wang Q; Luo S; Nong F; Wang X; Huang S; Chen J; Zhou L; Luo X
    Phytomedicine; 2020 Mar; 68():153179. PubMed ID: 32062328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,25-Dihydroxyvitamin D Protects Intestinal Epithelial Barrier by Regulating the Myosin Light Chain Kinase Signaling Pathway.
    Du J; Chen Y; Shi Y; Liu T; Cao Y; Tang Y; Ge X; Nie H; Zheng C; Li YC
    Inflamm Bowel Dis; 2015 Nov; 21(11):2495-506. PubMed ID: 26287999
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Han J; Li JH; Bai G; Shen GS; Chen J; Liu JN; Wang S; Liu XJ
    World J Gastroenterol; 2017 Mar; 23(12):2175-2184. PubMed ID: 28405145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atractylodes oil alleviates diarrhea-predominant irritable bowel syndrome by regulating intestinal inflammation and intestinal barrier via SCF/c-kit and MLCK/MLC2 pathways.
    Xie Y; Zhan X; Tu J; Xu K; Sun X; Liu C; Ke C; Cao G; Zhou Z; Liu Y
    J Ethnopharmacol; 2021 May; 272():113925. PubMed ID: 33592255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OTA induces intestinal epithelial barrier dysfunction and tight junction disruption in IPEC-J2 cells through ROS/Ca
    Wang H; Zhai N; Chen Y; Fu C; Huang K
    Environ Pollut; 2018 Nov; 242(Pt A):106-112. PubMed ID: 29966834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of p38 MAPK in burn-induced intestinal barrier breakdown.
    Costantini TW; Peterson CY; Kroll L; Loomis WH; Eliceiri BP; Baird A; Bansal V; Coimbra R
    J Surg Res; 2009 Sep; 156(1):64-9. PubMed ID: 19577248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myosin light chain kinase knockout improves gut barrier function and confers a survival advantage in polymicrobial sepsis.
    Lorentz CA; Liang Z; Meng M; Chen CW; Yoseph BP; Breed ER; Mittal R; Klingensmith NJ; Farris AB; Burd EM; Koval M; Ford ML; Coopersmith CM
    Mol Med; 2017 Aug; 23():155-165. PubMed ID: 28598488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide 2 attenuates intestinal mucosal barrier injury through the MLCK/pMLC signaling pathway in a piglet model.
    Chang Y; Deng Q; Zhang Z; Zhao H; Tang J; Chen X; Liu G; Tian G; Cai J; Jia G
    J Cell Physiol; 2021 Apr; 236(4):3015-3032. PubMed ID: 32960454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myosin light chain kinase mediates intestinal barrier disruption following burn injury.
    Chen C; Wang P; Su Q; Wang S; Wang F
    PLoS One; 2012; 7(4):e34946. PubMed ID: 22529961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Inulin-Type Fructan CP-A from
    Zhou J; Li D; Wang J; Cheng Z; Wang C; Zhang X; Xu X; Gao J
    Pharmaceuticals (Basel); 2024 Feb; 17(3):. PubMed ID: 38543083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chenodeoxycholic Acid (CDCA) Protects against the Lipopolysaccharide-Induced Impairment of the Intestinal Epithelial Barrier Function via the FXR-MLCK Pathway.
    Song M; Ye J; Zhang F; Su H; Yang X; He H; Liu F; Zhu X; Wang L; Gao P; Shu G; Jiang Q; Wang S
    J Agric Food Chem; 2019 Aug; 67(32):8868-8874. PubMed ID: 31319027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolic acid mediated disruption of the intestinal epithelial tight junctions.
    Qasim M; Rahman H; Ahmed R; Oellerich M; Asif AR
    Exp Cell Res; 2014 Apr; 322(2):277-89. PubMed ID: 24509232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic acid treatment inhibits hypoxia-inducible factor 1α accumulation and protects against burn-induced gut barrier dysfunction in a rodent model.
    Luo HM; Du MH; Lin ZL; Zhang L; Ma L; Wang H; Yu W; Lv Y; Lu JY; Pi YL; Hu S; Sheng ZY
    PLoS One; 2013; 8(10):e77523. PubMed ID: 24147016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.